Crossmark

Eficacia y seguridad de la profilaxis con emicizumab en la hemofilia A: estudio de 13 pacientes

Crossref DOI link: https://doi.org/10.1016/j.medcli.2023.07.024

Published Print: 2024-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ocaña Gómez, M. Ángeles

Ferrer Machín, Alejandro

Vera Cabrera, Martín

Álvarez Tosco, Karen Ilenia

Ríos de Paz, Mario

de Dios García, M. Dolores
License Information

Text and Data Mining valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01
More Information

This article is maintained by: Elsevier

Article Title: Eficacia y seguridad de la profilaxis con emicizumab en la hemofilia A: estudio de 13 pacientes

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2023.07.024

Content Type: simple-article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.